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Whatever the role of albumin in these two situations, these
studies again question the routine use of heparin in extracorporeal
circulation.
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RELEASE OF HISTAMINE BY H2-RECEPTOR
ANTAGONISTS
SiR,&mdash;Dr Czerwonka and colleagues (July 25, p 216) report that
an intravenous bolus injection of ranitidine and cimetidine did not
increase plasma histamine levels, as we had found.l They suggest
that in the method we used the observed increase in fluorescence
extinction might be caused by superprojection of the spectra of two
different fluorescing substrates. We do not accept this explanation.
Cimetidine2 does produce fluorophores with o-phthaldialdehyde
(OPD) at the conditions that are used for plasma histamine
measurement. However, the concentrations that elicit the same
fluorescence intensity as histamine at the wavelengths of the
histamine-OPD complex differ widely: 1 ng/ml histamine base (a
cut-off for clinically relevant histamine release 3) corresponds to
30, 40, and 150 &micro;g/ml cimetidine, ranitidine, and famotidine,
respectively. It is hard to believe that plasma levels as high as this are
present 5 min after an intravenous bolus injection of these drugs.
The fluorescence intensity of 0.1 1 ng/ml histamine might have been
imitated by that of the Hz-receptor antagonists but such increases in
luminescence are not interpreted by us as histamine released 1
Unfortunately, fig 2 in Czerwonka’s letter does not contain data on
fluorescence intensity (ordinate) needed to answer this question.
The fluorescence of Hz-receptor antagonists can be distinguished
from that of histamine by simple chemical tests which must be used
in any demonstration of clinically relevant histamine release by
drugs. Histamine-OPD fluorescence is destroyed by heating but
Plasma histamine levels, heart rate, and duration of clinical
symptoms (shaded area) in subject with systemic anaphylactoid
response to ranitidine, and comparison with exogenous
histamine.
C’ = plasma histamine;&bullet; heart rate.
FREQUENCY OF SYMPTOMS, BLOOD PRESSURE, AND HEART RATE
CHANGES, AND HISTAMINE RELEASE
Changes m heart rate > 5 beats/mm, changes m systolic BP > 5 mm Hg Tachycardia
explained by measured catecholamine increase mediated via adrenal H, receptors For the
lesser responses to saline see Lorenz et al s
that of cimetidine and ranitidine is not. Czerwonka should have
applied this test, as we do routinely.2,4
Histamine release by drugs must be demonstrated on criteria4,5
other than simply fluorescence in plasma 5 min after drug
injection-eg, the rapid onset of a rise in OPD-complex
luminescence and peaks at least 2 SD above baseline, and also by
biological effects of histamine release such as flush, metallic taste,
and headache (figure).
Histamine release by cimetidine has been confirmed by a
radioenzymatic assay6 based on a different chemical principle from
that of the fluorimetric test attacked by Czerwonka et al.
Since rapid injection of Hz-receptor antagonists can lead to
life-threatening arrhythmias and hypotensive reactions’ slow
injection or infusion has been recommended by manufacturers. Our
randomised study in volunteers given cimetidine or ranitidine
confirms the importance of histamine release. 30 healthy volunteers
(16 males, 14 females, aged 18-34) who gave written consent were
allocated at random to 5 mg/kg cimetidine or 1 ’25 mg/kg ranitidine
given intravenously in 20 s. The two groups were well matched, and
3/15 in the cimetidine group and 2/15 in the ranitidine group had a
history of allergy. After 30 min 600 ng/kg histamine was given as a
bolus injection (5 s). Reactions were compared by questionnaire3
and histamine was measured by combined fluorimetry (figure). A
histamine-release response of severity grade II3 was found in 6
volunteers receiving cimetidine and in 4 given ranitidine (table).
The assay described by Czerwonka et al is not yet published. It
may turn out to be unique in being able to detect fg/ml plasma
histamine (20 pg/ml in our "rough" method4) and whether it is
more specific than our fluorimetric assay remains to be seen too.
Either way, their letter should not be taken as meaning that rapid
intravenous injection ofH2-receptor blocking drugs does not result
in clinically significant histamine release.
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